middle.news
Epiminder Raises $125m IPO, Accelerates US Rollout of Minder Device
8:24am on Wednesday 25th of February, 2026 AEDT
•
Healthcare
Read Story
Epiminder Raises $125m IPO, Accelerates US Rollout of Minder Device
8:24am on Wednesday 25th of February, 2026 AEDT
Key Points
Completed $125 million IPO to fund commercialisation
Reported $21.7 million net loss, up from $15.4 million prior period
Minder device received FDA approval in April 2025
First Minder implant performed in the US in January 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
EPIMINDER (ASX:EPI)
OPEN ARTICLE